+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Creatinine Assay Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 110 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4987213

The Creatinine Assay Kits Market is expected to register a CAGR of 5.3% during the forecast period. Creatinine assay kits are used to measure creatinine levels in serum/plasma, urine and other biological samples. Creatinine is a waste product produced by muscles from the breakdown of creatine compound and removed from the body by the kidneys, which filter from the blood and release it into the urine. Creatinine assay is used to analyze the protein metabolism in the body and the levels of creatinine can be affected by changes in muscle mass, pregnancy, cancer, etc. Creatinine levels in the blood will increase and will deflect in the blood test if the kidney is not in the good condition. Creatinine test is performed by using specific creatinine assay kit and can be performed for different conditions like hypertension, diabetes and cancers. According to International Society of Nephrology, every year approximately 13.3 million cases of acute kidney injury (AKI) globally, particularly high in emerging countries, where annual incidence is estimated to be 11.3 million. Increasing incidence of renal disorders and other chronic disorders, technological advancements in biomedical research pertaining to kidney disorders and increasing research and development initiatives are the key driving factors in creatinine assay kits market.

Key Market Trends

Jaffe’s Kinetic Test Kits Segment is Expected to Hold a Major Market Share in the Creatinine Assay Kits Market

  • Jaffe reaction is a colorimetric method used in clinical chemistry to measure creatinine levels in blood and urine using Jaffe's Kinetic Test Kits.
  • According to the National Kidney Foundation, about 10% of the population worldwide is affected by chronic kidney disease (CKD), and millions die each year with kidney disease.
  • Jaffe’s Kinetic Test Kits segment hold a significant market share in the creatinine assay kits market and is anticipated to show a similar trend over the forecast period due to being the conventional method for creatinine measurement and the wide product availability, as well as the cost-effectiveness of these kits.
  • Increasing incidence of renal disorders and other chronic disorders impacting renal function, technological advancements in biomedical research pertaining to kidney disorders are the key driving factors in the Jaffe’s kinetic test kits segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global creatinine assay kits market due to increasing incidence of renal disorders and other chronic disorders impacting renal function and technological advancements in biomedical research pertaining to kidney disorders in this region. According to the Centers for Disease Control and Prevention (CDC), approximately 30 million people or 15% of United States adults are estimated to have chronic kidney disease (CKD). chronic kidney disease (CKD) is estimated to be more common in women (16%) than in men (13%). Furthermore, favourable reimbursement policies and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Creatinine Assay Kits Market is highly fragmented competitive and consists of several major players. In terms of market share, majority of the players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Quidel Corporation, Cell Biolabs, Inc, Genway Biotech, Randox Laboratories Ltd, ACON Laboratories, Nova Biomedical and Sysmex India Pvt. Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Renal and Other Chronic Disorders Impacting Renal Function
4.2.2 Technological Advancements in Biomedical Research Pertaining to Kidney Disorders
4.2.3 Increasing Research and Development Initiatives
4.3 Market Restraints
4.3.1 Identification of Novel Renal Dysfunction Biomarkers
4.3.2 Limited Usage of Creatinine Assay Kits in Invitro Diagnostic Device (IVD)
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 Jaffe's Kinetic Test kits
5.1.2 Creatinine-PAP Test kits
5.1.3 ELISA Test kits
5.2 By Type of Sample
5.2.1 Blood/Serum
5.2.2 Urine
5.2.3 Other Samples
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Thermo Fisher Scientific
6.1.3 Merck KGaA
6.1.4 Quidel Corporation
6.1.5 Cell Biolabs, Inc
6.1.6 Genway Biotech
6.1.7 Randox Laboratories Ltd
6.1.8 ACON Laboratories
6.1.9 Nova Biomedical
6.1.10 Sysmex India Pvt. Ltd

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Merck KGaA
  • Quidel Corporation
  • Cell Biolabs, Inc
  • Genway Biotech
  • Randox Laboratories Ltd
  • ACON Laboratories
  • Nova Biomedical
  • Sysmex India Pvt. Ltd